Inclusion of Under-Represented Racial and Ethnic Groups in Cardiovascular Clinical Trials

被引:21
|
作者
Vilcant, Viliane [1 ]
Ceron, Carlos [1 ]
Verma, Gagan [2 ]
Zeltser, Roman [1 ,2 ]
Makaryus, Amgad N. [1 ,2 ]
机构
[1] Nassau Univ Med Ctr, E Meadow, NY 11554 USA
[2] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY 11549 USA
来源
HEART LUNG AND CIRCULATION | 2022年 / 31卷 / 09期
关键词
Racial minorities; Ethnic minorities; Underrepresentation; Race; Ethnicity; Cardiology; Trials; DISPARITIES; ENROLLMENT; MINORITIES; MORTALITY; HEALTH;
D O I
10.1016/j.hlc.2022.06.668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Non-White racial and ethnic groups have been traditionally under-represented for decades in the field of cardiology, specifically in cardiovascular research studies. This underrepresentation has occurred despite the fact that these racial and ethnic groups have been shown to be at increased risk of cardiovascular disease (CVD). Methods To assess the trend of representation in mainstream landmark cardiovascular trials, we performed a review of major cardiovascular trials published between 1986 and 2019. Mainstream landmark trials were selected as classified by established cardiology standards. The reported numbers of racial and ethnic participants were assessed within these categorised cardiovascular trials over a continuous time period. Results A total of 1,138,683 patients were assessed from 153 randomised clinical trials. Of these trials, only 56% (n=86) reported information about race. Of note, 99% (n=152) of these trials reported gender. About three-quarters of the trials (77%) were undertaken at least partly in the United States (US). Our results show that the percentage of non-White participants in clinical trials was not significantly different over time (p=0.85), suggesting no significant improvement in non-White racial/ethnic representation. Further analysis of only the US inclusive trials (n=20) also showed no significant improvement in representation (p=0.38). Conclusion Only about half of all major cardiovascular landmark trials reported any racial or ethnic information, despite more recent calls over the last 5-10 years for diversity and representation in cardiovascular research studies. Additionally, no significant improvement in inclusion of traditionally under-represented racial and ethnic groups (UREGs) in these trials has occurred over time. Our analysis shows that there is still major work to be done to foster better representation and evaluation of the UREG population in cardiovascular trials.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [21] Enabling skin research participation of under-represented ethnic minority populations: a codesigned inclusion toolkit
    Choy, Shern Ping
    Naveed, Maneeha
    Prasad, Jasmine
    Quadry, Koyinsola
    Moorhead, Lucy
    Smith, Catherine
    Mahil, Satveer K.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I34 - I35
  • [22] Introduction: Are British Ethnic Minorities Politically Under-represented?
    Fieldhouse, Edward
    Sobolewska, Maria
    PARLIAMENTARY AFFAIRS, 2013, 66 (02) : 235 - 245
  • [23] Older patients are still under-represented in clinical trials of Alzheimer’s disease
    Rita Banzi
    Paolo Camaioni
    Mauro Tettamanti
    Vittorio Bertele’
    Ugo Lucca
    Alzheimer's Research & Therapy, 8
  • [24] Older patients are still under-represented in clinical trials of Alzheimer's disease
    Banzi, Rita
    Camaioni, Paolo
    Tettamanti, Mauro
    Bertele, Vittorio
    Lucca, Ugo
    ALZHEIMERS RESEARCH & THERAPY, 2016, 8
  • [25] Evaluating admission criteria effects for under-represented groups
    Childs, Ruth A.
    Ferguson, Amanda K.
    Herbert, Monique B.
    Broad, Kathryn
    Zhang, Jingshun
    HIGHER EDUCATION RESEARCH & DEVELOPMENT, 2016, 35 (04) : 658 - 668
  • [26] Deliberative Democracy, Under-Represented Groups and Inclusiveness in Europe
    Gherghina, Sergiu
    Mokre, Monika
    Miscoiu, Sergiu
    INNOVATION-THE EUROPEAN JOURNAL OF SOCIAL SCIENCE RESEARCH, 2021, 34 (05) : 633 - 637
  • [27] The future of warfarin pharmacogenetics in under-represented minority groups
    Cavallari, Larisa H.
    Perera, Minoli A.
    FUTURE CARDIOLOGY, 2012, 8 (04) : 563 - 576
  • [28] Women are under-represented in the Clinical Excellence Awards
    Hill, Oscar W.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [29] Why are ethnic minorities under-represented in US research studies?
    Sheikh, A
    PLOS MEDICINE, 2006, 3 (02) : 166 - 167
  • [30] Poulations from under-represented backgrounds are not adequately represented in clinical databases
    Barnes, Kathleen
    FASEB JOURNAL, 2019, 33